We are live on ! Find out more
BPMC

Blueprint Medicines

Delisted

BPMC was delisted on the 17th of July, 2025.

5 hedge funds and large institutions have $2.58M invested in Blueprint Medicines in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 344 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

99% less funds holding

Funds holding: 3545 (-349)

99.54% less ownership

Funds ownership: 99.58%0.04% (-100%)

100% less capital invested

Capital invested by funds: $8.24B → $2.58M (-$8.24B)

100% less funds holding in top 10

Funds holding in top 10: 290 (-29)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 344

Holders
5
Holders Change
-349
Holders Change %
-98.59%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
-29
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
1
Reduced
3
Closed
344
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Zurich Cantonal Bank
176
Zurich Cantonal Bank
Switzerland
-$2.2M -17,194 Closed
Walleye Capital
177
Walleye Capital
New York
-$2.16M -16,830 Closed
TIP
178
Torray Investment Partners
Maryland
-$2.13M -16,615 Closed
SSA
179
Schonfeld Strategic Advisors
New York
-$2.08M -16,228 Closed
DIA
180
Dana Investment Advisors
Wisconsin
-$2.05M -16,031 Closed
State Board of Administration of Florida Retirement System
181
State Board of Administration of Florida Retirement System
Florida
-$1.94M -15,172 Closed
SCM
182
SCS Capital Management
Massachusetts
-$1.94M -15,163 Closed
ACM
183
ADAR1 Capital Management
Texas
-$1.92M -15,000 Closed
MTCM
184
Mint Tower Capital Management
Netherlands
-$1.92M -15,000 Closed
GC
185
Guggenheim Capital
Illinois
-$1.87M -14,624 Closed
MAM
186
Martingale Asset Management
Massachusetts
-$1.87M -14,592 Closed
PFSRSONJ
187
Police & Firemen's Retirement System of New Jersey
New Jersey
-$1.85M -14,423 Closed
Canada Life
188
Canada Life
Manitoba, Canada
-$1.82M -14,186 Closed
WAM
189
Weiss Asset Management
Massachusetts
-$1.78M -13,873 Closed
ORI
190
Oak Ridge Investments
Illinois
-$1.77M -13,808 Closed
PA
191
Profund Advisors
Maryland
-$1.69M -13,210 Closed
CUAMC
192
China Universal Asset Management Company
China
-$1.66M -12,971 Closed
FC
193
FORA Capital
Florida
-$1.61M -12,589 Closed
LCM
194
Landscape Capital Management
New Jersey
-$1.6M -12,468 Closed
IC
195
IEQ Capital
California
-$1.6M -12,450 Closed
SCI
196
S&CO Inc
Massachusetts
-$1.54M -12,000 Closed
Capital Fund Management (CFM)
197
Capital Fund Management (CFM)
France
-$1.52M -11,820 Closed
Victory Capital Management
198
Victory Capital Management
Texas
-$1.49M -11,625 Closed
Skandinaviska Enskilda Banken (SEB)
199
Skandinaviska Enskilda Banken (SEB)
Sweden
-$1.47M -11,500 Closed
Los Angeles Capital Management
200
Los Angeles Capital Management
California
-$1.43M -11,138 Closed

BPMC Hedge Fund Activity: Q3 2025 in Review

5 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Blueprint Medicines (BPMC) for Q3 2025, worth a combined $2.58M — down 100% from $8.24B a quarter earlier.

Sellers outnumbered buyers: 344 funds closed out of BPMC and 0 opened new positions — a net loss of 344 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was IFP Advisors, adding an estimated $2.06K. The largest seller was Vanguard Group, exiting entirely with an estimated $822M sold.

  • 5 institutional investors held Blueprint Medicines (BPMC) as of Q3 2025, down from 354 in Q2 2025.
  • Funds reported $2.58M of Blueprint Medicines stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Blueprint Medicines positions in Q3 2025 and 344 closed out, a net change of -344 holders.
  • The largest Blueprint Medicines buyer in Q3 2025 was IFP Advisors, an estimated $2.06K added.
  • The largest Blueprint Medicines seller in Q3 2025 was Vanguard Group, an estimated $822M sold.

Based on aggregated 13F filings for Q3 2025.